Chase Investment Counsel’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-4,929
Closed -$2.33M 151
2026
Q1
$2.33M Sell
4,929
-16
-0.3% -$8.05K 0.61% 43
2025
Q4
$2.31M Buy
4,945
+19
+0.4% +$8.82K 0.65% 42
2025
Q3
$2.1M Sell
4,926
-11,100
-69% -$4.3M 0.62% 46
2025
Q2
$6.14M Buy
+16,026
New +$5.77M 1.96% 18
2015
Q4
Sell
-56,382
Closed -$4.36M 93
2015
Q3
$4.36M Buy
+56,382
New +$4.99M 1.76% 28

Other funds holding HCA

Chase Investment Counsel's HCA Position: Q2 2026 in Review

Chase Investment Counsel sold out of HCA Healthcare (HCA) in Q2 2026, closing a stake of 4,929 shares — an estimated $2.33M sold.

Chase Investment Counsel first reported a position in HCA in Q3 2015 and held it in 5 quarters. The position peaked at $6.14M in Q2 2025. 1,333 funds tracked by Wall St. Rank hold HCA as of Q2 2026.

  • Chase Investment Counsel reported no remaining HCA Healthcare position as of Q2 2026 after selling out during the quarter.
  • Chase Investment Counsel sold 4,929 HCA Healthcare shares in Q2 2026, an estimated $2.33M.
  • Chase Investment Counsel first reported a position in HCA Healthcare in Q3 2015 and held it in 5 quarters.
  • Chase Investment Counsel's HCA Healthcare position peaked at $6.14M in Q2 2025.
  • 1,333 funds tracked by Wall St. Rank held HCA Healthcare as of Q2 2026.

Based on Chase Investment Counsel's 13F filing for Q2 2026, filed 6 Aug 2026.